Journal Logo

Most Popular Articles

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet

Itzykson, Raphael; Fenaux, Pierre; Bowen, David; More

HemaSphere. 2(6):e150, December 2018.

Insights on Multiple Myeloma Treatment Strategies

Mateos, María-Victoria; Ludwig, Heinz; Bazarbachi, Ali; More

HemaSphere. 3(1):e163, February 2019.

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study

Joy Ho, P.; Hiwase, Devendra; Ramakrishna, Raj; More

HemaSphere. 3(3):e224, June 2019.

A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality Consortium

Armand, Marine; Derrieux, Coralie; Beldjord, Kheira; More

HemaSphere. 3(3):e255, June 2019.

A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia

Grioni, Andrea; Fazio, Grazia; Rigamonti, Silvia; More

HemaSphere. 3(3):e250, June 2019.

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS)

Verelst, Silvia G.R.; Blommestein, Hedwig M.; De Groot, Saskia; More

HemaSphere. 2(4):e45, August 2018.

Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion

Decool, Gauthier; Domenech, Carine; Grardel, Nathalie; More

HemaSphere. 3(3):e193, June 2019.

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML

Duployez, Nicolas; Martin, Jean-Edouard; Khalife-Hachem, Sabine; More

HemaSphere. 3(3):e203, June 2019.

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Alduaij, Waleed; McNamara, Caroline J.; Schuh, Andre; More

HemaSphere. 2(3):e44, June 2018.

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

Bizymi, Nikoleta; Bjelica, Suncica; Kittang, Astrid Olsnes; More

HemaSphere. 3(1):e168, February 2019.

LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone

Jutzi, Jonas S.; Kleppe, Maria; Dias, Jennifer; More

HemaSphere. 2(3):e54, June 2018.

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML

Schwarer, Anthony P.; Butler, Jason; Jackson, Kathryn; More

HemaSphere. 2(6):e158, December 2018.

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study

Herfarth, Klaus; Borchmann, Peter; Schnaidt, Sven; More

HemaSphere. 2(6):e160, December 2018.

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia

Gavriilaki, Eleni; Christodoulou, Ioanna; Koravou, Eudoxia-Evaggelia; More

HemaSphere. 2(5):e58, October 2018.

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group

Engert, Andreas; Goergen, Helen; Markova, Jana; More

HemaSphere. 1(1):e5, December 2017.

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?

Papalexandri, Apostolia; Saloum, Riad; Touloumenidou, Tasoula; More

HemaSphere. 2(6):e157, December 2018.

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

Coutre, Steven E.; Flinn, Ian W.; de Vos, Sven; More

HemaSphere. 2(3):e39, June 2018.

Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

Jentzsch, Madlen; Bill, Marius; Grimm, Juliane; More

HemaSphere. 3(1):e167, February 2019.

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

Sujobert, Pierre; Le Bris, Yannick; de Leval, Laurence; More

HemaSphere. 3(1):e169, February 2019.

A Novel Inducible Mouse Model of MLL-ENL-driven Mixed-lineage Acute Leukemia

Stavropoulou, Vaia; Almosailleakh, Marwa; Royo, Hélène; More

HemaSphere. 2(4):e51, August 2018.

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism

van der Wall, Sake J.; Klok, Frederikus A.; den Exter, Paul L.; More

HemaSphere. 2(1):e19, January-February 2018.

Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma

Murray, Suzanne; Mohty, Mohamad; Peloquin, Sophie; More

HemaSphere. 2(2):e33, March-April 2018.

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

Marceau-Renaut, Alice; Duployez, Nicolas; Ducourneau, Benoît; More

HemaSphere. 2(1):e31, January-February 2018.

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial

Petit, Arnaud; Ducassou, Stéphane; Leblanc, Thierry; More

HemaSphere. 2(6):e159, December 2018.

Is Good Clinical Practice Becoming Poor Clinical Care?

Le Gouill, Steven; Dreyling, Martin; Caballero, Maria Dolores; More

HemaSphere. 1(1):e4, December 2017.

Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency

Airiau, Kelly; Turcq, Béatrice; Bouchet, Stéphane; More

HemaSphere. 2(3):e41, June 2018.

Show: